MedTrace Logo

Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery

NCT03856788 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-10-17

Study results available
· View outcomes & findings →

Summary

The study team will be assessing if the unilateral subcostal transversus abdominis plane (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy surgeries.

Conditions

  • Laparoscopic Sleeve Gastrectomy
  • Subcostal Transversus Abdominis Plane Block

Interventions

DRUG

Saline

40 mL sterile normal saline

DRUG

Bupivacaine

40 mL 0.25% bupivacaine

Sponsors & Collaborators

Principal Investigators

  • Christina Jeng, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2021-03-25
Completion
2021-03-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03856788 on ClinicalTrials.gov